Free Trial
NASDAQ:MDWD

MediWound (MDWD) Stock Price, News & Analysis

MediWound logo
$19.47 +0.35 (+1.83%)
Closing price 07/3/2025 03:05 PM Eastern
Extended Trading
$19.32 -0.15 (-0.77%)
As of 07/3/2025 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About MediWound Stock (NASDAQ:MDWD)

Key Stats

Today's Range
$19.20
$19.47
50-Day Range
$17.25
$22.24
52-Week Range
$14.14
$24.00
Volume
10,185 shs
Average Volume
86,194 shs
Market Capitalization
$210.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$31.80
Consensus Rating
Buy

Company Overview

MediWound Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
26th Percentile Overall Score

MDWD MarketRank™: 

MediWound scored higher than 26% of companies evaluated by MarketBeat, and ranked 695th out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MediWound has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    MediWound has only been the subject of 3 research reports in the past 90 days.

  • Read more about MediWound's stock forecast and price target.
  • Earnings Growth

    Earnings for MediWound are expected to grow in the coming year, from ($2.66) to ($2.24) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MediWound is -9.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MediWound is -9.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    MediWound has a P/B Ratio of 6.74. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about MediWound's valuation and earnings.
  • Percentage of Shares Shorted

    12.32% of the float of MediWound has been sold short.
  • Short Interest Ratio / Days to Cover

    MediWound has a short interest ratio ("days to cover") of 13, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in MediWound has recently decreased by 3.91%, indicating that investor sentiment is improving.
  • Dividend Yield

    MediWound does not currently pay a dividend.

  • Dividend Growth

    MediWound does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    12.32% of the float of MediWound has been sold short.
  • Short Interest Ratio / Days to Cover

    MediWound has a short interest ratio ("days to cover") of 13, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in MediWound has recently decreased by 3.91%, indicating that investor sentiment is improving.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for MediWound this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, MediWound insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 9.20% of the stock of MediWound is held by insiders.

  • Percentage Held by Institutions

    46.83% of the stock of MediWound is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about MediWound's insider trading history.
Receive MDWD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MediWound and its competitors with MarketBeat's FREE daily newsletter.

MDWD Stock News Headlines

"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
See More Headlines

MDWD Stock Analysis - Frequently Asked Questions

MediWound's stock was trading at $17.80 on January 1st, 2025. Since then, MDWD stock has increased by 9.4% and is now trading at $19.47.

MediWound Ltd. (NASDAQ:MDWD) issued its quarterly earnings data on Wednesday, May, 21st. The biopharmaceutical company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.65) by $0.58. The biopharmaceutical company earned $3.96 million during the quarter, compared to the consensus estimate of $5.20 million. MediWound had a negative trailing twelve-month return on equity of 74.12% and a negative net margin of 110.45%.
Read the conference call transcript
.

MediWound's stock reverse split on Tuesday, December 20th 2022.The 1-7 reverse split was announced on Tuesday, December 20th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, December 20th 2022. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

Shares of MDWD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MediWound investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Adobe (ADBE), ServiceNow (NOW) and Palo Alto Networks (PANW).

Company Calendar

Last Earnings
5/21/2025
Today
7/05/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MDWD
Employees
80
Year Founded
2001

Price Target and Rating

Average Stock Price Target
$31.80
High Stock Price Target
$39.00
Low Stock Price Target
$25.00
Potential Upside/Downside
+63.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$30.22 million
Net Margins
-110.45%
Pretax Margin
-110.23%

Debt

Sales & Book Value

Annual Sales
$20.22 million
Price / Cash Flow
N/A
Book Value
$2.89 per share
Price / Book
6.74

Miscellaneous

Free Float
9,814,000
Market Cap
$210.47 million
Optionable
Optionable
Beta
0.32

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:MDWD) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners